690 — Uni-Bio Science Balance Sheet
0.000.00%
- HK$668.78m
- HK$614.07m
- HK$552.98m
- 59
- 61
- 59
- 66
Annual balance sheet for Uni-Bio Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 61 | 83.6 | 98.2 | 129 | 170 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 88.3 | 71.6 | 57.9 | 59.5 | 101 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 181 | 202 | 200 | 238 | 319 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 62.3 | 57.8 | 67.6 | 120 | 148 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 253 | 268 | 292 | 410 | 518 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 60.4 | 92.3 | 90.3 | 115 | 123 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 63.3 | 93.3 | 97.7 | 153 | 192 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 189 | 174 | 195 | 257 | 326 |
Total Liabilities & Shareholders' Equity | 253 | 268 | 292 | 410 | 518 |
Total Common Shares Outstanding |